BACKGROUND: Historically, the primary hazard with liver surgery has been intraoperative
blood loss. This led to the refinement of inflow and outflow occlusive techniques. The utility of …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor patient
survival. Toward understanding the underlying molecular alterations that drive PDAC …

Metabolomics, the newest of the “omics” sciences, has brought much excitement to the field
of oncology as a potential new translational tool capable of bringing the molecular world of …

Cholangiocarcinoma (CCA) is an aggressive malignancy of the bile ducts, with poor
prognosis and limited treatment options. Here, we describe the integrated analysis of somatic …

We present a proteogenomic study of 108 human papilloma virus (HPV)-negative head and
neck squamous cell carcinomas (HNSCCs). Proteomic analysis systematically catalogs …

Surgery represents the main curative therapeutic modality for gastric cancer, and it is
occasionally considered for palliation as well as prophylaxis. Most frequently, surgical outcomes …

Purpose Current prognostic factors are poor at identifying patients at risk of disease
recurrence after surgery for stage II colon cancer. Here we describe a DNA microarray–based …

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is an autosomal-dominant
cancer-predisposition syndrome with a significant risk of gastric, but not colorectal, …

… Author links open overlay panel Ioannis G Kaklamanos MD, PhD a , Oliver F Bathe MD a ,
Dido Franceschi MD a , Christina Camarda MD a , Joe Levi MD a , Alan S Livingstone MD a …

Background: We postulated that the abundance of various metabolites in blood would
facilitate the diagnosis of pancreatic and biliary lesions, which could potentially prevent …